Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CHRONIC LYMPHOCYTIC B-LEUKEMIA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01671904
What this trial is testing

Venetoclax in Combination With Bendamustine + Rituximab or Bendamustine + Obinutuzumab in Participants With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
Genentech, Inc. 84
Testing effectiveness (Phase 2)Study completedNCT00001873
What this trial is testing

The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers

Who this might be right for
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseHematologic Neoplasm+2 more
National Heart, Lung, and Blood Institute (NHLBI) 102
Not applicableActive Not RecruitingNCT05140369
What this trial is testing

CLL Therapy Approaches in Russia

Who this might be right for
Chronic Lymphocytic Leukemia
AstraZeneca 6,000
Testing effectiveness (Phase 2)Study completedNCT00364286
What this trial is testing

Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825)

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 17
Testing effectiveness (Phase 2)Ended earlyNCT01625741
What this trial is testing

Phase II Study of High-Dose Rituximab in High-Risk Chronic Lymphocytic Leukemia Patients in Suboptimal Response After Induction Immunochemotherapy

Who this might be right for
Chronic Lymphocytic Leukemia
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 6
Early research (Phase 1)Study completedNCT00275080
What this trial is testing

Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+48 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT00006379
What this trial is testing

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Case Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Testing effectiveness (Phase 2)Active Not RecruitingNCT04623541
What this trial is testing

Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome

Who this might be right for
Relapsed/Refractory Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaRichter's Syndrome+1 more
Genmab 194
Early research (Phase 1)Study completedNCT03454165
What this trial is testing

BNC105P Combined With Ibrutinib

Who this might be right for
Chronic Lymphocytic Leukemia
Dartmouth-Hitchcock Medical Center 6
Testing effectiveness (Phase 2)Study completedNCT01096992
What this trial is testing

Fludarabine, Bendamustine, and Rituximab (FBR) for Relapsed Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 51
Not applicableWithdrawnNCT00770419
What this trial is testing

Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersDepression+7 more
Rutgers, The State University of New Jersey
Testing effectiveness (Phase 2)Ended earlyNCT05317936
What this trial is testing

Pirtobrutinib (LOXO-305) Consolidation for MRD Eradication in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL) Treated With Venetoclax

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
M.D. Anderson Cancer Center 3
Early research (Phase 1)Study completedNCT00036257
What this trial is testing

Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Astellas Pharma Inc 15
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Not applicableLooking for participantsNCT06821880
What this trial is testing

Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project

Who this might be right for
Chronic Lymphocytic Leukaemia (CLL)Multiple Myeloma (MM)Secondary Immunodeficiency (SID)
Medical University Innsbruck 120
Early research (Phase 1)Study completedNCT01098188
What this trial is testing

LFB-R603 Dose Finding in Patients With Advanced Stage B-Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Laboratoire français de Fractionnement et de Biotechnologies 33
Testing effectiveness (Phase 2)Ended earlyNCT01612988
What this trial is testing

Treatment With Bendamustine, Ofatumumab and MethylPrednisolone in Relapsed B-CLL

Who this might be right for
B-cell Chronic Lymphocytic Leukemia (B-CLL)
French Innovative Leukemia Organisation 74
Early research (Phase 1)Study completedNCT01732861
What this trial is testing

Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma

Who this might be right for
Leukemia Lymphocytic Chronic B-Cell
Celgene 20
Large-scale testing (Phase 3)Study completedNCT02242942
What this trial is testing

Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Lymphocytic Leukemia, Chronic
Hoffmann-La Roche 445
Next Page